Human Resources in
2019
2020
2021
2.749.000
Turnover (value in EUR/000)
Among the first 50
companies in the world
21%
reinvested in R&D
Our Areas of Work
Patients are the purpose of our business: they are at the centre of all our activities, processes, and decisions.
The Chiesi Group research, develops, and markets innovative drugs in three specific areas:
Our Values
Our goal is to combine commitment to results, drive sustainable progress, and operate in a socially and environmentally responsible manner.
As a certified B Corp, we hallenge ourselves in a process of continuous improvement, addressing high standards of verified social and environmental performance, public transparency, and legal accountability to balance profit and purpose. We are guided by the concept of shared value – an approach that aims at generating economic value in a way which also benefits society by addressing its needs and challenges.
Our values of integrity, inclusivity and trust define our identity as a company, and our dedication to use our business as a force for good.
Research and Development
We are committed to providing innovative therapeutic solutions for our patients. Research and development play a key role in our work, by enabling advanced technologies and innovations to improve both our products and our processes.
Over 21% of our revenues are dedicated to R&D every year, employing 1.102 people which 687 researchers. In the past years, the Group has been expanding its venture into biopharmaceutical research.
Our Global Footprint
We export to over 100 countries worldwide, and we have a direct presence in 31. Our production operations are spread between Italy (Parma), France (Blois), and Brazil (Santana de Parnaiba).
The Chiesi Group’s main R&D activities are based in Parma, where a new Biotech Center of Excellence is set to be operational in 2024. The research in Parma is integrated with six other major research hubs, in France, the United States, Canada, China, the United Kingdom, and Sweden.
News and Press Releases
